Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $4.02-$12.73 |
Market Cap | $466.2M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $851.6M |
Revenue Growth (YoY) | -44.7% |
Gross Profit (12 Mos) | $480.2M |
Diluted EPS | $2.62 |
News
See moreYahoo Finance • 3 days ago
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
Yahoo Finance • 8 days ago
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
Yahoo Finance • 12 days ago
Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA
About
CEO | Mr. Joseph C. Papa Jr., M.B.A., R.Ph. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |
